RESUMO
The investigation was concerned with the role of enzymouria in the assessment of nephrotoxic effects identified in 19 children with malignant solid tumors who received cisplatin polychemotherapy in a dose of 100 mg/sq.m or iphosphamide in a dose 9 g/sq.m. Chemotherapy application was followed by a persistent hyperenzymouria involving significantly higher levels of N-acetyl-beta-D-hexosaminidase, beta-glutamyl transferase and alanine aminopeptidase in the urine, as compared with basal indices. Iphosphamide treatment showed significantly higher levels of enzymouria than those in cisplatin-treated patients. Higher than normal creatinine and urea concentrations were recorded only in 2 out of 9 patients receiving iphosphamide. Enzymouria evaluation was shown to be an effective method of nephrotoxic diagnosis.
Assuntos
Antineoplásicos/efeitos adversos , Neoplasias/sangue , Neoplasias/urina , Insuficiência Renal/sangue , Insuficiência Renal/urina , Adolescente , Antineoplásicos Alquilantes/efeitos adversos , Criança , Pré-Escolar , Cisplatino/efeitos adversos , Creatinina/sangue , Creatinina/urina , Feminino , Humanos , Ifosfamida/efeitos adversos , Masculino , Neoplasias/tratamento farmacológico , Insuficiência Renal/induzido quimicamente , Ureia/sangue , Ureia/urinaAssuntos
Ácido Araquidônico/metabolismo , Neoplasias Ósseas/tratamento farmacológico , Osteossarcoma/tratamento farmacológico , Prostaglandina-Endoperóxido Sintases/metabolismo , Adolescente , Adulto , Neoplasias Ósseas/metabolismo , Neoplasias Ósseas/patologia , Quimioterapia Adjuvante , Humanos , Osteossarcoma/metabolismo , Osteossarcoma/patologiaRESUMO
The results of chemotherapy administered to 47 cancer outpatients (a total of 222 cycles) were studied. Leukopenia, alopecia, nausea and vomiting, mostly moderate, were the most frequent side-effects. Outpatient chemotherapy proved as effective as that given under hospital conditions.